A Drug-Drug Interaction Study of HDM1002 and Metformin, Empagliflozin, Midazolam, Valsartan, and Warfarin

NCT07331389 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

111

Enrollment

INDUSTRY

Sponsor class

Conditions

Overweight Subject
Healthy Subjects

Interventions

DRUG: Metformin
DRUG: Empagliflozin
DRUG: Midazolam
DRUG: Valsartan
DRUG: Warfarin
DRUG: HDM1002

Sponsor

Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.